Literature DB >> 26381810

BDNF Val66Met Polymorphism Is Related to Motor System Function After Stroke.

Dae Yul Kim1, Erin B Quinlan2, Robert Gramer3, Steven C Cramer4.   

Abstract

BACKGROUND: The val(66)met polymorphism in brain-derived neurotrophic factor (BDNF) has been associated with poorer outcomes after stroke. The mechanism for this finding remains uncertain but might be related to the reduced motor system activation associated with this polymorphism in healthy people.
OBJECTIVE: The current study examined whether the presence of the BDNF val(66)met polymorphism is associated with reduced motor system activation after stroke. DESIGN AND METHODS: Forty-two patients with stroke who were enrolled in 1 of 2 studies of robot-assisted arm motor therapy participated in the study. All participants were tested for the BDNF val(66)met polymorphism followed by functional magnetic resonance imaging during affected hand movement.
RESULTS: Participants averaged 12 months poststroke and had wide-ranging motor deficits (Fugl-Meyer scale scores=14-60). Brain activation in participants without the BDNF val(66)met polymorphism (n=26) spanned bilateral motor networks with a larger volume (total=334 cc) than that found in participants with this polymorphism (n=16) (97 cc). Regional analyses were consistent. Participants without this polymorphism showed larger ipsilesional primary sensorimotor cortex activation volume and magnitude compared with those in whom the polymorphism was present. LIMITATIONS: The extent to which these findings generalize to other populations of people with stroke, such as those with stroke <7 days prior, remains uncertain.
CONCLUSIONS: Functional magnetic resonance imaging during affected hand movement showed decreased brain activation among participants with the BDNF val(66)met polymorphism compared with those lacking this polymorphism, especially in the ipsilesional primary sensorimotor cortex contralateral to movement. These results echo findings in healthy people and suggest that genetic factors affecting the normal brain continue to be operative after stroke. The findings suggest a potential imaging-based endophenotype for the BDNF val(66)met polymorphism's effect on the motor system that may be useful in a clinical trial setting.
© 2016 American Physical Therapy Association.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26381810      PMCID: PMC4817211          DOI: 10.2522/ptj.20150135

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  46 in total

Review 1.  Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic.

Authors:  Zheng Gang Zhang; Michael Chopp
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

Review 2.  Disentangling the heterogeneity of autism spectrum disorder through genetic findings.

Authors:  Shafali S Jeste; Daniel H Geschwind
Journal:  Nat Rev Neurol       Date:  2014-01-28       Impact factor: 42.937

Review 3.  Promoting neuroplasticity for motor rehabilitation after stroke: considering the effects of aerobic exercise and genetic variation on brain-derived neurotrophic factor.

Authors:  Cameron S Mang; Kristin L Campbell; Colin J D Ross; Lara A Boyd
Journal:  Phys Ther       Date:  2013-08-01

4.  Correlation between genetic polymorphisms and stroke recovery: analysis of the GAIN Americas and GAIN International Studies.

Authors:  S C Cramer; V Procaccio
Journal:  Eur J Neurol       Date:  2012-01-04       Impact factor: 6.089

Review 5.  Biomarkers of recovery after stroke.

Authors:  Marie-Hélène Milot; Steven C Cramer
Journal:  Curr Opin Neurol       Date:  2008-12       Impact factor: 5.710

6.  Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype.

Authors:  B F L van Nuenen; M M Weiss; B R Bloem; K Reetz; T van Eimeren; K Lohmann; J Hagenah; P P Pramstaller; F Binkofski; C Klein; H R Siebner
Journal:  Neurology       Date:  2008-11-26       Impact factor: 9.910

Review 7.  Exercise: a behavioral intervention to enhance brain health and plasticity.

Authors:  Carl W Cotman; Nicole C Berchtold
Journal:  Trends Neurosci       Date:  2002-06       Impact factor: 13.837

8.  Targeted engagement of a dorsal premotor circuit in the treatment of post-stroke paresis.

Authors:  Lucy Dodakian; Kelli G Sharp; Jill See; Neil S Abidi; Khoa Mai; Brett W Fling; Vu H Le; Steven C Cramer
Journal:  NeuroRehabilitation       Date:  2013       Impact factor: 2.138

9.  Neural markers of errors as endophenotypes in neuropsychiatric disorders.

Authors:  Dara S Manoach; Yigal Agam
Journal:  Front Hum Neurosci       Date:  2013-07-18       Impact factor: 3.169

10.  A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS.

Authors:  Binith Cheeran; Penelope Talelli; Francesco Mori; Giacomo Koch; Antonio Suppa; Mark Edwards; Henry Houlden; Kailash Bhatia; Richard Greenwood; John C Rothwell
Journal:  J Physiol       Date:  2008-10-09       Impact factor: 5.182

View more
  12 in total

Review 1.  Spontaneous and Therapeutic-Induced Mechanisms of Functional Recovery After Stroke.

Authors:  Jessica M Cassidy; Steven C Cramer
Journal:  Transl Stroke Res       Date:  2016-04-25       Impact factor: 6.829

Review 2.  Genetic Variation and Neuroplasticity: Role in Rehabilitation After Stroke.

Authors:  Jill Campbell Stewart; Steven C Cramer
Journal:  J Neurol Phys Ther       Date:  2017-07       Impact factor: 3.649

3.  Low Serum Levels of Brain-Derived Neurotrophic Factor Were Associated with Poor Short-Term Functional Outcome and Mortality in Acute Ischemic Stroke.

Authors:  Jing Wang; Li Gao; Yan-Long Yang; Yu-Qian Li; Tao Chang; Ming-Hao Man; Xing-Ye Zhang; Shao-Chun Guo; Li-Hong Li
Journal:  Mol Neurobiol       Date:  2016-11-04       Impact factor: 5.590

4.  Brain-derived neurotrophic factor in peripheral blood mononuclear cells and stroke outcome.

Authors:  Martin Pedard; Céline Brenière; Nicolas Pernet; Catherine Vergely; Yannick Béjot; Christine Marie
Journal:  Exp Biol Med (Maywood)       Date:  2018-11-24

5.  Genetic Factors, Brain Atrophy, and Response to Rehabilitation Therapy After Stroke.

Authors:  Steven C Cramer; Jill See; Brent Liu; Matthew Edwardson; Ximing Wang; Shlomit Radom-Aizik; Fadia Haddad; Babak Shahbaba; Steven L Wolf; Alexander W Dromerick; Carolee J Winstein
Journal:  Neurorehabil Neural Repair       Date:  2021-12-21       Impact factor: 3.919

6.  Brain-Derived Neurotrophic Factor Gene Polymorphism Predicts Response to Continuous Theta Burst Stimulation in Chronic Stroke Patients.

Authors:  Shreya Parchure; Denise Y Harvey; Priyanka P Shah-Basak; Laura DeLoretta; Rachel Wurzman; Daniela Sacchetti; Olufunsho Faseyitan; Falk W Lohoff; Roy H Hamilton
Journal:  Neuromodulation       Date:  2021-07-12

7.  BDNF genotype and tDCS interaction in aphasia treatment.

Authors:  Julius Fridriksson; Jordan Elm; Brielle C Stark; Alexandra Basilakos; Chris Rorden; Souvik Sen; Mark S George; Michelle Gottfried; Leonardo Bonilha
Journal:  Brain Stimul       Date:  2018-08-18       Impact factor: 8.955

8.  Brain-Derived Neurotrophic Factor Gene Polymorphism Predicts Response to Continuous Theta Burst Stimulation in Chronic Stroke Patients.

Authors:  Shreya Parchure; Denise Y Harvey; Priyanka P Shah-Basak; Laura DeLoretta; Rachel Wurzman; Daniela Sacchetti; Olufunsho Faseyitan; Falk W Lohoff; Roy H Hamilton
Journal:  Neuromodulation       Date:  2021-07-12

Review 9.  Application of Transcranial Direct Current Stimulation in Neurorehabilitation: The Modulatory Effect of Sleep.

Authors:  James K Ebajemito; Leonardo Furlan; Christoph Nissen; Annette Sterr
Journal:  Front Neurol       Date:  2016-04-06       Impact factor: 4.003

10.  BDNF Val66Met Genetic Polymorphism Results in Poor Recovery Following Repeated Mild Traumatic Brain Injury in a Mouse Model and Treatment With AAV-BDNF Improves Outcomes.

Authors:  Anna O Giarratana; Shavonne Teng; Sahithi Reddi; Cynthia Zheng; Derek Adler; Smita Thakker-Varia; Janet Alder
Journal:  Front Neurol       Date:  2019-11-07       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.